| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 33,815 | 30,306 | 36,006 | 38,629 | | Cost of Revenue | 28,694 | 24,149 | 26,888 | 28,365 | | | Gross Profit | 5,121 | 6,157 | 9,118 | 10,264 | | | Operating Expenses | | Research Development | (5,513) | 5,513 | (1,721) | 1,721 | | Selling General and Administrative | 12,301 | 870 | 9,026 | 4,830 | | Non Recurring | 238 |
-
| (238) | 238 | | Others | 5,364 |
-
|
-
|
-
| | | | Total Operating Expenses | 12,390 |
-
|
-
|
-
| | | | Operating Income or Loss | (1,905) | (226) | 2,051 | 3,475 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (743) | 4,468 | (2,585) | 143 | | Earnings Before Interest And Taxes | (8,012) | 4,242 | (534) | 3,618 | | Interest Expense | (4,533) | 4,999 | (1,588) | 2,533 | | Income Before Tax | (3,479) | (757) | 1,054 | 1,085 | | Income Tax Expense | 302 | 673 | 580 | 550 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,781) | (1,430) | 474 | 535 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,781) | (1,430) | 474 | 535 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,781) | ($1,430) | $474 | $535 |
|
0.13% Nasdaq 
Income Statement
